share_log

ThinkEquity Initiates Coverage On Vivani Medical With Buy Rating, Announces Price Target of $7

Benzinga Real-time News ·  Dec 5, 2022 09:18

ThinkEquity analyst Ashok Kumar initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy rating and announces Price Target of $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment